Method and agents for detecting luciferase activity
US-2024018566-A1 · Jan 18, 2024 · US
US9499853B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9499853-B2 |
| Application number | US-201214236531-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 2, 2012 |
| Priority date | Aug 2, 2011 |
| Publication date | Nov 22, 2016 |
| Grant date | Nov 22, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure relates to biosensing systems and biosensing elements having increased storage capability and increased functional lifetimes through using compositions and methods for recycling cofactors.
Opening claim text (preview).
The invention claimed is: 1. A biosensing system that measures the concentration of an analyte in a solution, said biosensing system comprising a first biocomponent that catalyzes the reaction of said analyte and oxygen and uses a cofactor selected from the group consisting of NADH, NADPH, FADH, FADH 2 , FMNH, FMNH 2 , and a second biocomponent that catalyzes the reaction of a cofactor selected from the group consisting of NAD + , NADP + , FADH, FMNH, FAD and FMN, and an electron donor, and wherein said first biocomponent and said second biocomponent are immobilized within a matrix, and wherein said matrix is in contact with a transducer layer, and wherein said transducer layer is part of an optode. 2. The biosensing system of claim 1 wherein said transducer layer is an optical transducer that constitutively fluoresces and wherein the fluorescence is quenched during use by oxygen in an oxygen-containing solution. 3. The biosensing system of claim 1 wherein said first biocomponent is selected from the group consisting of monooxygenases and dioxygenases. 4. The biosensing system of claim 1 wherein said second biocomponent is formate dehydrogenase and said electron donor is formate. 5. The biosensing system of claim 1 further comprising a tip of a capillary tube, wherein said capillary tube contains formic acid or a salt of formate anion, such that formate is delivered through capillary action to said first and second biocomponent. 6. The biosensing system of claim 1 , wherein said analyte is a reactant in a reaction catalyzed by of an oxygenase enzyme, said oxygenase enzyme selected from the group consisting of Enzyme Commission numbers 1.13 and 1.14, and wherein said oxygenase enzyme requires a reduced cofactor selected from the group consisting of NADH, NADPH, FADH, FADH 2 , FMNH, and FMNH 2 , and wherein said first biocomponent comprises said oxygenase enzyme, and wherein said second biocomponent comprises a dehydrogenase enzyme that catalyzes the reaction of an oxidized cofactor selected from the group consisting of NAD + , NADP + , FADH, FMNH, FAD and FMN and an electron donor, and wherein a third biocomponent comprises an enzyme selected from the group consisting of epoxide hydrolase, glutathione synthetase, glutathione S-transferase and gamma-glutamylcysteine sythetase, and wherein said first biocomponent catalyzes the reaction of said analyte and said cofactor selected from the group consisting of NADH, NADPH, FADH, FADH 2 , FMNH, and FMNH 2 while consuming oxygen and producing oxidized cofactor and an epoxide product, and wherein said oxidized cofactor is reduced by said second biocomponent and said electron donor, and wherein said epoxide product is a reactant in the reaction catalyzed by said third biocomponent, and wherein a transducer layer fluoresces photons, and wherein oxygen quenches at least some of the fluorescent photons, and wherein said photons enter into a fiber optic cable and are transmitted to a photomultiplier, and wherein said photomultiplier produces an output signal that is coupled to an algorithm that transforms the signal generated by said photomultiplier into an output correlated to the concentration of said analyte in said solution. 7. The biosensing system of claim 6 wherein said first biocomponent is toluene ortho-monooxygenase. 8. The biosensing system of claim 6 wherein said first biocomponent is toluene ortho-monooxygenase-Green. 9. The biosensing system of claim 6 wherein said second biocomponent is formate dehydrogenase and said electron donor is formate. 10. The biosensing system of claim 1 , wherein said optode comprises a fiber optical cable having a first tip and a second tip, and said first tip is covered by said transducer layer, and said transducer layer is covered by a biocomponent layer comprising said first and second biocomponent within said matrix, and said biocomponent layer is covered by a porous layer, and said second tip is coupled to a photon-detection device, and said photon-detection device is coupled to a signal processing system, and said analyte concentration in said solution, the depth of the biocomponent layer, the depth of the porous layer, the diffusion coefficient of said porous layer, the K m and V max of the reaction between said biocomponent and said analyte are selected such that the quotient between Da e and 4β is from about 10 to about 1000. 11. The biosensing system of claim 10 wherein said biocomponent layer comprises toluene ortho-monooxygenase, toluene ortho-monooxygenase-Green, or toluene ortho-monooxygenase Green and formate dehydrogenase. 12. The biosensing system of claim 10 wherein said biocomponent comprises toluene ortho-monooxygenase-Green, formate dehydrogenase and at least one enzyme selected from the group consisting of epoxide hydrolase, glutathione synthetase, glutathione S-transferase and gamma-glutamylcysteine sythetase. 13. The biosensing system of claim 10 wherein said transducer layer comprises RuDPP. 14. The biosensing system of claim 10 wherein said porous layer is track-etched polycarbonate. 15. The biosensing system of claim 1 wherein said first biocomponent and said second biocomponent are within or on the surface of a whole cell biocomponent that is immobilized within a matrix, and wherein said matrix is adhered to said transducer layer. 16. A method for measuring the concentration of an analyte in a solution using a biosensing system wherein said biosensing system comprises biocomponents, and wherein a first biocomponent of said biosensing system is an oxygenase enzyme that catalyzes a reaction that uses oxygen, said analyte and a reduced cofactor as reactants and produces oxidized cofactor, and wherein a second biocomponent of said biosensing system is a dehydrogenase enzyme that catalyzes a reaction that uses said oxidized cofactor and an electron donor as reactants and produces said reduced cofactor, and wherein said reduced cofactor is used in the reaction catalyzed by said first biocomponent, and wherein the oxygen concentration in said solution is measured by said biosensing system, and wherein the measured oxygen concentration in said solution is used to calculate the measurement of the concentration of said analyte in said solution. 17. The method of claim 16 wherein said biosensing system further comprises a transducer layer that fluoresces photons, and wherein oxygen quenches the emission of at least some of the fluorescent photons, and wherein said photons enter into a fiber optic cable and are transmitted to a photomultiplier, and wherein said photomultiplier produces an output signal that is coupled to an algorithm that transforms the signal generated by said photomultiplier into an output correlated to the concentration of said analyte in said solution. 18. The method of claim 16 wherein said first biocomponent is toluene ortho-monooxygenase or toluene ortho-monooxygenase-Green; and said second biocomponent is formate dehydrogenase and said electron donor is formate. 19. The method of claim 16 wherein said analyte is a reactant in the reaction catalyzed by an oxygenase enzyme, and wherein said oxygenase enzyme requires a cofactor selected from the group consisting of NADH, NADPH, FADH, FADH 2 , FMNH, FMNH 2 , and wherein said second biocomponent comprises a dehydrogenase enzyme that catalyzes the reaction of an oxidized cofactor selected from the group consisting of NAD + , NADP + , FADH, FMNH, FAD and FMN, and an electron donor, and wherein a third b
Quenching · CPC title
Measuring fluorescence of biological material, e.g. DNA, RNA, cells (G01N21/6428 takes precedence) · CPC title
with measurement of decay time, time resolved fluorescence · CPC title
Apparatus specially designed for the use of free, immobilised, or carrier-bound enzymes, e.g. apparatus containing a fluidised bed of immobilised enzymes · CPC title
Measuring or testing with condition measuring or sensing means, e.g. colony counters · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.